General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Planococcus massiliensis is a Gram-positive, non-spore-forming, strictly aerobic, motile, rod-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 46.0%. Planococcus massiliensis is likely to be transient and not a long-term gut coloniser. (Seck2015)



  • This organism has been recovered from human faeces. Pathogenicity status unknown, or very unlikely to be pathogenic. Likely to be transient and not a long-term gut commensal.

  • QUIRKS
  • Obligate aerobe; unlikely to be a gut coloniser.

  • GENERAL CHARACTERISTICS (Seck2015);
    Character Response
  • 🧂
  • Salt tolerance:
  • doesn't tolerate 0% salt; tolerates 20% salt;
  • pH
  • Acidity tolerance:
  • tolerates pH 6.0; tolerates pH 9; Grows optimally at pH 7.0-8.0.
  • 🌡
  • Temperature tolerance:
  • grows at 25℃; grows at 40℃; Grows optimally at 37℃.
  • H+
  • Acid from carbohydrates usually produced:
  • D-arabinose; fructose; glucose; mannose; ribose;
  • Active enzymes:
  • esterase C4; esterase lipase C8; α-glucosidase; oxidase; naphthol-ASBI-P;

  • SPECIAL FEATURES (Seck2015);
    Character Response
  • Metabolites not produced:
  • indole;
  • Nitrate:
  • not reduced

  • RESPONSE TO ANTIBIOTICS (Seck2015);
    Class Active Resistant
  • Penicillins:
  • amoxicillin; ampicillin; imipenem; penicillin;
  • Tetracyclines:
  • doxycycline;
  • Quinolines:
  • ciprofloxacin;
  • Aminoglycosides:
  • gentamicin;
  • Polypep/ketides:
  • rifampicin;
  • Heterocycles:
  • nitrofurantoin; trimethoprim-sulfamethoxazole;
  • Vancomycins:
  • vancomycin;

  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Firmicutes Class:  Bacilli Order:  Caryophanales Family:  Caryophanaceae Genus:  Planococcus Gram stain:  + O2 Relation.:  strictly aerobic Spore:  No spore Motility:  Swimming Morphology:  Rod
    Health:  Unknown
    Source:  human faeces
    DNA G+C(%):  46.0
    Opt. T:  37℃
    Lower T(℃):  25(+)
    Mid T(℃):  40(+)
    NaCl 0.5-2%:  0(neg)
    NaCl >6%:  20(+)
    Opt. pH:  7.0-8.0
    pH 6.0-8.0:  6.0(+)
    pH >8:  9(+)
    Urea:  neg

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    D-Arabinose:  + L-Arabinose:  neg Fructose:  + Glucose:  + Mannose:  + Ribose:  + Lactose:  neg Maltose:  neg Sucrose:  neg Mannitol:  neg

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  + Catalase:  neg Urease:  neg Ac-β-glcamnd:  neg α-Fucosidase:  neg α-Galactosidase:  neg β-Galactosidase:  neg α-Glucosidase:  + β-Glucosidase:  neg β-Glucuronidase:  neg α-Mannosidase:  neg ArgDH:  neg Chymotrypsin:  neg Trypsin:  neg CystineAA:  neg LeuAA:  neg ValAA:  neg AlkalineP:  neg AcidP:  neg Esterase(C4):  + EstLip(C8):  +

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Indole:  neg

    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    amoxicillin:  Sens
    ampicillin:  Sens
    penicillin:  Sens
    imipenem:  Sens
    gentamicin:  Sens
    ciprofloxacin:  Sens
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    doxycycline:  Sens
    vancomycin:  Sens
    rifampicin:  Sens
    nitrofurantoin:  Sens
    SXT:  Sens

    References


    SPECIFIC REFERENCES FOR PLANOCOCCUS MASSILIENSIS
  • Seck2015 - Noncontiguous finished genome sequence and description of Planococcus massiliensis sp. nov., a moderately halophilic bacterium isolated from the human gut.
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR PLANOCOCCUS MASSILIENSIS
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • ...............................